Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine?

Bibliography

• Lance JW, Goadsby PJ. Mechanism and management of headache. 7th edition. Elsevier, New York; 2005
   Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 2004;24(Suppl 1):1-160
   Google Scholar
• Tepper SJ, Dahlof CG, Dowson A, Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the landmark study. Headache 2004;44:856-64
   PubMed Web of Science ®Google Scholar
• Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol 1995;48:269-80
   PubMed Web of Science ®Google Scholar
• Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005;12(Suppl 1):1-27
   PubMed Web of Science ®Google Scholar
• Stewart WF, Ricci JA, Chee E, Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-54
   PubMed Web of Science ®Google Scholar
• Menken M, Munsat TL, Toole JF. The global burden of disease study – implications for neurology. Arch Neurol 2000;57:418-20
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Engl J Med 2002;346:257-70
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Charbit AR, Andreou AP, Neurobiology of migraine. Neuroscience 2009;161:327-41
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Bartsch T, Dodick DW. Occipital nerve stimulation (ONS) for headache: mechanisms and efficacy. Headache 2008;48:313-8
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Goadsby PJ. Migraine as a cerebral ionopathy with abnormal central sensory processing. In: Gilman S, editor, Neurobiology of disease. Elsevier, New York; 2007. p. 333-48
   Google Scholar
• Stovner LJ, Tronvik E, Hagen K. New drugs for migraine. J Headache Pain 2009;10:395-406
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Emerging therapies for migraine. Nat Clin Pract Neurol 2007;3:610-9
   PubMedGoogle Scholar
• Goadsby PJ. Calcitonin gene-related peptide (CGRP) antagonists and migraine – is this a new era? Neurology 2008;70:1300-1
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Schoenen J, Ferrari MD, Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006;26:1168-70
   PubMed Web of Science ®Google Scholar
• Debanne D, Daoudal G, Sourdet V, Russier M. Brain plasticity and ion channels. J Physiol Paris 2003;97:403-14
   PubMedGoogle Scholar
• Perez-Otano I, Ehlers MD. Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 2005;28:229-38
   PubMed Web of Science ®Google Scholar
• Asztely F, Gustafsson BI. Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol 1996;12:1-11
   PubMed Web of Science ®Google Scholar
• Weiler IJ, Greenough WT. Metabotropic glutamate receptors trigger postsynaptic protein synthesis. Proc Natl Acad Sci USA 1993;90:7168-71
   PubMed Web of Science ®Google Scholar
• Albin RL, Makowiec RL, Hollingsworth ZR, Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 1992;46:35-48
   PubMed Web of Science ®Google Scholar
• Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 1992;322:121-35
   PubMed Web of Science ®Google Scholar
• Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution on the mRNA for a metabolic glutamate receptor, mGluR3, in the rat brain: an in situ hybridization study. J Comp Neurol 1993;335:252-66
   PubMed Web of Science ®Google Scholar
• Testa CM, Standaert DG, Young AB, Penney JB. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 1994;14:3005-18
   PubMed Web of Science ®Google Scholar
• Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL. Localization of mGlur1-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res 1998;780:210-7
   PubMed Web of Science ®Google Scholar
• Romano C, Sesma MA, McDonald CT, Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 1995;355:455-69
   PubMed Web of Science ®Google Scholar
• Abe T, Sugihara H, Nawa H, Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 1992;267:13361-8
   PubMed Web of Science ®Google Scholar
• Shigemoto R, Nomura S, Ohishi H, Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 1993;163:53-7
   PubMed Web of Science ®Google Scholar
• Liang Y-C, Huang C-C, Hsu K-S. Characterization of the long term potentiation of primary afferent transmission at trigeminal synapses of juvenile rats :essential role of subType 5 or metabotropic glutamate receptors. Pain 2005;114:417-28
   PubMed Web of Science ®Google Scholar
• Frisby CL, Mattsson JP, Jensen JM, Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005;129:995-1004
   PubMed Web of Science ®Google Scholar
• Greenamyre JT, Young AB, Penney JB. Quantitative autoradiographic distribution of L-[3H]glutamate-binding sites in rat central nervous system. J Neurosci 1984;4:2133-44
   PubMed Web of Science ®Google Scholar
• Kai-Kai MA, Howe R. Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and intraspinal neurons and fibres in the dorsal horn of the rat. Histochem J 1991;23:171-9
   PubMedGoogle Scholar
• Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neuroscience Lett 1992;141:79-83
   PubMed Web of Science ®Google Scholar
• Halpain S, Wieczorek CM, Rainbow TC. Localization of L-glutamate receptors in rat brain by quantitative autoradiography. J Neurosci 1984;4:2247-58
   PubMed Web of Science ®Google Scholar
• Watanabe M, Mishina M, Inoue Y. Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland. Neurosci Lett 1994;165:183-6
   PubMed Web of Science ®Google Scholar
• Sahara Y, Noro N, Iida Y, Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci 1997;17:6611-20
   PubMed Web of Science ®Google Scholar
• Tamaru Y, Nomura S, Mizuno N, Shigemoto R. Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 2001;106:481-503
   PubMed Web of Science ®Google Scholar
• Hill RG, Salt TE. An iontophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli. J Physiol 1982;327:65-78
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Classey JD. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res 2000;875:119-24
   PubMed Web of Science ®Google Scholar
• Bereiter DA, Bereiter DF, Hathaway CB. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the rat. Pain 1996;64:179-89
   PubMed Web of Science ®Google Scholar
• Oshinsky ML, Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache 2006;46(Suppl 1):S39-44
   PubMedGoogle Scholar
• Xiao Y, Richter JA, Hurley JH. Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling. Mol Pain 2008;4:12
   PubMed Web of Science ®Google Scholar
• Ma QP. Co-localisation of 5HT1B/1D/1F receptors and glutamate in trigeminal ganglion in rats. Neuroreport 2001;12:1589-91
   PubMed Web of Science ®Google Scholar
• Silva E, Quinones B, Freund N, Extracellular glutamate, aspartate and arginine increase in the ventral posterolateral thalamic nucleus during nociceptive stimulation. Brain Res 2001;923:45-9
   PubMed Web of Science ®Google Scholar
• Salt TE. Glutamate receptor functions in sensory relay in the thalamus. Philos Trans R Soc Lond B Biol Sci 2002;357:1759-66
   PubMed Web of Science ®Google Scholar
• Award H, Hubert GW, Smith Y, Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci 2000;20:7871-9
   PubMed Web of Science ®Google Scholar
• Nicolodi M, Sicutieri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Pharmacol Res 1995;15:181-9
   PubMedGoogle Scholar
• Kaube H, Herzog J, Kaufer T, Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000;55:139-41
   PubMed Web of Science ®Google Scholar
• Storer RJ, Goadsby PJ. N-Methyl-d-Aspartate receptor channel complex blockers including memantine and magnesium inhibit nociceptive traffic in the trigeminocervical complex of the rat. Cephalalgia 2009;29(Suppl 1):135
   Google Scholar
• Charles A, Flippen C, Romero Reyes M, Brennan KC. Memantine for prevention of migraine: a retrospective study of 60 cases. J Headache Pain 2007;8:248-50
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Keywood C. Investigation of the role of mGluR5 inhibition in migraine: a proof of concept study of ADX10059 in acute treatment of migraine. Neurology 2009;72(Suppl 1):A285
   Google Scholar
• Saper J, Goadsby PJ, Silberstein S, Dodick DW. Occipital nerve stimulation (ONS) for treatment of intractable chronic migraine (ICM): 3-Month Results from the ONSTIM Feasibility Study. Neurology 2009;72(Suppl 3):A252
   Google Scholar
• Lipton RB, Goadsby PJ, Cady RK, PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia 2009;29(Suppl 1):30
   Google Scholar
• Dodick DW, Smith TR, Becker WJ, Botulinum neurotoxin type A for treatment of chronic migraine: PREEMPT 2 trial double-blind phase. Cephalalgia 2009;29(Suppl 1):29
   Google Scholar
• Reuter U, Pilgrim AJ, Diener H-C, COL-144, a selective 5-HT1F agonist, for the treatment of migraine attacks. Cephalalgia 2009;29:122
   Google Scholar
• Ho TW, Ferrari MD, Dodick DW, Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008;372:2115-23
   PubMed Web of Science ®Google Scholar